ログインで組織・契約価格をご覧ください。
サイズを選択してください
表示を変更する
| サイズ/SKU | 在庫状況 | 単価 |
|---|---|---|
5 mg | 在庫 | ¥22,800 |
25 mg | カートの在庫状況を確認する | ¥72,800 |
この商品について
Form:
powder
製品名
Syrosingopine,
form
powder
Quality Segment
color
white to light brown
solubility
DMSO: 10 mg/mL, clear
SMILES string
O=C(OC)[C@@H]1[C@]2([H])C[C@@]3([H])C4=C(C5=CC=C(OC)C=C5N4)CCN3C[C@]2([H])C[C@H](OC(C6=CC(OC)=C(OC(OCC)=O)C(OC)=C6)=O)[C@H]1OC
InChI
1S/C35H42N2O11/c1-7-46-35(40)48-31-26(42-3)12-18(13-27(31)43-4)33(38)47-28-14-19-17-37-11-10-22-21-9-8-20(41-2)15-24(21)36-30(22)25(37)16-23(19)29(32(28)44-5)34(39)45-6/h8-9,12-13,15,19,23,25,28-29,32,36H,7,10-11,14,16-17H2,1-6H3/t19-,23+,25-,28-,29+,32+/m1/s1
InChI key
ZCDNRPPFBQDQHR-SSYATKPKSA-N
Application
Syrosingopine has been used as a monocarboxylate transporter (MCT) inhibitor
- to study its effects on anti-CD147-induced metabolon disruption in human breast cancer cells
- to study its effects on Cryptosporidium parvum-infected HCT-8 cells
- in orthogonal linear separation analysis (OLSA)-derived decomposed analysis
Biochem/physiol Actions
Syrosingopine is an antihypertensive agent related to reserpine that was found to potentiate the anticancer effects of the antidiabetic agent metformin and phenformin without harmful effects on normal cells.
Syrosingopine is an antihypertensive agent related to reserpine that was found to potentiate the anticancer effects of the antidiabetic agent metformin and phenformin without harmful effects on normal cells. Syrosingopine was also found to potentiate the anticancer activity of mitochondrial electron transport chain (ETC) inhibitors. Its mechanism of action is currently unknown but may involve inhibition of glycolytic enzyme α-enolase rather than its known activity as an inhibitor of vesicular monoamine transporters VMAT1 and VMAT2.
保管分類
11 - Combustible Solids
一体何が起きているの?
WGK 3
引火点 (F)
Not applicable
引火点(°C)
Not applicable